Diarylamide WS6, which was previously suggested to target IKKε with increasing β-cell proliferation potency in primary human islet culture9,11, increased β-cell regeneration much less efficiently than PIAA in the zebrafish model of type 1 diabetes (data not shown). Here, IKBKE is linked to type 1 diabetes mellitus.